Revenue $2.45B, down 1.2% on a year earlier. Diluted EPS -$16.24 against $1.34.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $2.45B | $2.46B | $2.48B | -1.2% |
| Operating income | -$910.30M | $95.42M | $146.98M | -719.3% |
| Net income | -$988.11M | $55.28M | $88.11M | -1221.5% |
| Diluted EPS | -$16.24 | $0.86 | $1.34 | |
| Operating cash flow | $268.21M | $257.89M | $224.80M | +19.3% |
| Capital expenditures | -$46.98M | -$48.17M | -$65.05M | |
| Free cash flow | $221.23M | $209.72M | $159.75M | +38.5% |
| Dividend per share | $0.36 | $0.36 | — |
| Q3 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|
| Constant Currency Revenue Growth | -0.5% | 2.6% | |
| Revenue Growth | -1.19% | 4.01% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Concentrix (CNXC) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/CNXC/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
